Clinical Trials Directory

Trials / Completed

CompletedNCT05752929

Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients

Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients in an Institution in Bogotá, Colombia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
116 (actual)
Sponsor
Hospital Universitario Clinica San Rafael · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Hyperglycemia in the hospital is associated with multiple adverse outcomes. Previously, the mobile insulin scheme was used for its control. However, in the last decade, several studies have shown that the insulin basal-bolus (basal plus) regimen is associated with better glycemic control and a lower risk of hypoglycemia.

Detailed description

Introduction: Hyperglycemia in the hospital is associated with multiple adverse outcomes. Previously, the mobile insulin scheme was used for its control. However, in the last decade, several studies have shown that the insulin basal-bolus (basal plus) regimen is associated with better glycemic control and a lower risk of hypoglycemia. Objective: To compare the sensitive scheme of Umpierrez and the correction factor suggested by Davidson (1700/total dose of insulin) for the correction of hyperglycemia in patients with type 1 diabetes mellitus. Methods: Unblinded, randomized, controlled clinical trial in patients with hyperglycemia and type 2 diabetes mellitus hospitalized at a hospital in Bogotá, Colombia, between 2016 and 2018. A probabilistic sampling with randomly permuted blocks was performed. The Umpierrez sensitive correction scheme and the Davidson correction factor were compared by evaluating glycemic control at 2 and 5 hours, and the presence of hypoglycemia.

Conditions

Interventions

TypeNameDescription
DRUGInsulincorrection scheme with Rapid Acting Insulin Analogs according with the Umpierrez sensitive correction scheme
DRUGinsulincorrection scheme with Rapid Acting Insulin Analogs according with the Davidson correction scheme

Timeline

Start date
2016-01-01
Primary completion
2018-12-31
Completion
2019-12-31
First posted
2023-03-03
Last updated
2023-03-03

Source: ClinicalTrials.gov record NCT05752929. Inclusion in this directory is not an endorsement.